Survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) reported lasting sequelae with insufficient postdischarge education and support, a qualitative survey study showed.

Stevens-Johnson syndrome (SJS) is a rare and severe kind of erythema multiforme (EM). It is a severe skin reaction that is frequently caused by drugs. SJS frequently starts with a fever and flu-like ...

The mother of a 10-year-old girl who suffered blisters across most of her body after she took pain medication has spoken out about the terrifying ordeal. Alexa Juckiewicz-Caspell from Essex, U.K., ...

A Valley boy is fighting to a make a full recovery right now at the Arizona Burn Center in Phoenix. Noah Barnes has been in the hospital for a month. He had a severe allergic reaction to a medication ...

A young mom’s rare reaction to a prescription medication left her body burning from the inside out. Nicole Donald, 26, was diagnosed with bipolar disorder in 2020 and was prescribed a range of pills ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. There is no standardized prediction system for ...

New findings reveal significant long-term challenges for SJS/TEN survivors and gaps in follow-up care. Learn more about the ...

Earlier this month, Kyle Viljoen announced that he was being monitored in the hospital after suffering highly unusual symptoms. At first, doctors misdiagnosed him with hand-foot-and-mouth disease.

A 23-year-old New Zealand woman is sharing her "terrifying" reaction to medication she took for depression, claiming it "burned me from the inside out" and nearly killed her. Facebook / Charlotte ...

Most cases of SJS are probably a cell-mediated hypersensitivity reaction; in some cases monocytes and macrophages are present and auto-antibodies may be pathogenic. SJS is characterized by skin ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Pharmigene, a leader in advancing personalized medicine and reducing severe adverse drug reactions through genetic-based diagnostic solutions, today announced the ...